Strengthening Core Competencies, Basic Research and Product Development Capabilities
First written in FY2016. 20 of 30 entries say "Restated". Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「At the Fluid Solutions Center, comprising the Asago LAB and Yokohama LAB facilities, the company conducts evaluation tests using actual fluids brought in by customers. Based on the practical feedback obtained there, it is promoting the development of original products that meet customer needs. Total R&D spending for the current consolidated fiscal year was ¥442 million.」
The company continued its R&D structure for testing actual fluids at the two Asago LAB and Yokohama LAB facilities, and R&D spending was ¥442 million. - FY2026-H1RestatedAnnual report
「R&D spending during the first half of the current consolidated fiscal year was ¥216 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D spending for the first half was ¥216 million, and the company explained that there were no material changes in the status of its R&D activities. - FY2025AdvancedAnnual report
「The company will also accelerate proposals for solving fluid-related challenges using Smooth Flow Pumps by strengthening collaboration with universities, companies and research institutions.」
The company expanded its R&D structure by establishing two locations, Asago LAB and Yokohama LAB, and through collaboration with universities, companies and research institutions. R&D spending was ¥383 million. - FY2024AdvancedAnnual report
「Total R&D spending for the current consolidated fiscal year was ¥344 million.」
The company advanced research into basic and elemental technologies, measurement technologies and the development of the Q Series, and R&D spending was ¥344 million. - FY2024-Q3RestatedAnnual report
「R&D spending during the first 3 quarters of the current consolidated fiscal year was ¥246 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D spending for the first 3 quarters was ¥246 million, but the company explained that there were no material changes in the status of its R&D activities. - FY2023-Q3RestatedAnnual report
「R&D spending during the first 3 quarters of the current consolidated fiscal year was ¥207 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D spending for the first 3 quarters was ¥207 million, and the company explained that there were no material changes in the status of its R&D activities. - FY2023-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥145 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there was no material change in its research and development activities and reported cumulative second-quarter research and development expenses of ¥145 million. - FY2022AdvancedAnnual report
「For the water treatment, sterilisation and disinfection markets, we advanced the development of high-value-added products tailored to customer needs and research and development of next-generation technologies, using know-how gained through research into measurement technologies essential for water-quality management in addition to the fluid-control technologies cultivated to date. Total research and development expenses for the current consolidated fiscal year were ¥285 million.」
The company added research into measurement technologies required for water-quality management and advanced research and development of high-value-added products and next-generation technologies for water treatment, sterilisation and disinfection applications. Research and development expenses amounted to ¥285 million. - FY2022-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥210 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reported cumulative third-quarter research and development expenses of ¥210 million and no material change in the status of its research and development activities. - FY2022-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥146 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reported cumulative second-quarter research and development expenses of ¥146 million and no material change in the status of its research and development activities. - FY2022-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥77 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company reported cumulative first-quarter research and development expenses of ¥77 million and no material change in the status of its research and development activities. - FY2021AdvancedAnnual report
「To serve the water treatment, sterilisation and disinfection markets, we established a new Instrumentation Equipment Development Section. In addition to the fluid-control technologies cultivated to date, we used know-how gained through research into measurement technologies essential for water-quality management to develop high-value-added products tailored to customer needs and advance research and development of next-generation technologies. Total research and development expenses for the current consolidated fiscal year were ¥275 million.」
The company established a new Instrumentation Equipment Development Section for water treatment, sterilisation and disinfection applications and advanced research and development, including measurement technologies. Research and development expenses were reported at ¥275 million. - FY2021-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥205 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reported cumulative third-quarter research and development expenses of ¥205 million, while stating that there was no material change in the status of its research and development activities. - FY2021-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥138 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there was no material change in its research and development activities and reported cumulative second-quarter research and development expenses of ¥138 million. - FY2021-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥70 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company reported cumulative first-quarter research and development expenses of ¥70 million and no material change in the status of its research and development activities. - FY2020RestatedAnnual report
「We will also accelerate efforts to resolve fluid-related challenges through Smooth Flow Pumps by strengthening collaboration with universities, companies and research institutions.」
The company is reaffirming its policy of enhancing product development capabilities through advanced fluid analysis at LAB II and collaboration with universities, companies and research institutions. - FY2020-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥201 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reported cumulative third-quarter research and development expenses of ¥201 million and no material change in the status of its research and development activities. - FY2020-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥144 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reported no material change in the status of its research and development activities and cumulative second-quarter research and development expenses of ¥144 million. - FY2020-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥71 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company reported cumulative first-quarter research and development expenses of ¥71 million and no material change in the status of its research and development activities. - FY2019AdvancedAnnual report
「The core technologies of Smooth Flow Pumps include diaphragms and valve seats. We are accumulating know-how to improve the quality and speed of product development and enhancement through research into the materials and shapes of these components, as well as repeated analysis, simulations and evaluation tests based on a range of intended applications. Total research and development expenses for the current consolidated fiscal year were ¥280 million.」
The company continued research into elemental technologies such as diaphragms and valve seats, along with analysis, simulations and evaluation testing, and research and development expenses amounted to ¥280 million. - FY2019-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥203 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reported cumulative third-quarter research and development expenses of ¥203 million and no material change in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥146 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reported cumulative second-quarter research and development expenses of ¥146 million and no material change in the status of its research and development activities. - FY2018AdvancedAnnual report
「The core technologies of Smooth Flow Pumps include diaphragms and valve seats. We are accumulating know-how to improve the quality and speed of product development and enhancement through research into the materials and shapes of these components, as well as repeated analysis, simulations and evaluation tests based on a range of intended applications. Total research and development expenses for the current consolidated fiscal year were ¥273 million.」
The company continued research into elemental technologies such as diaphragms and valve seats, along with analysis and evaluation testing, and research and development expenses amounted to ¥273 million. - FY2018-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥132 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reported no material change in the status of its research and development activities and cumulative second-quarter research and development expenses of ¥132 million. - FY2018-Q1AdvancedAnnual report
「In July 2017, an experimental facility, Fluid Solutions Center LAB II, was completed and began operating within the Development Center. The facility enables us to conduct pump research with customers according to the liquid involved. We will continue to further expand the applications of Smooth Flow Pumps.」
Fluid Solutions Center LAB II, which conducts pump research with customers according to the liquid involved, was completed and began operating in July 2017, giving concrete form to the research and development infrastructure. - FY2017AdvancedAnnual report
「To this end, we are actively investing in the construction of a new research and development building and facilities enabling more advanced fluid analysis. We will also accelerate efforts to resolve market challenges through Smooth Flow Pumps by strengthening collaboration with universities, companies and research institutions.」
The company has given concrete form to investment in a new research and development building and advanced fluid-analysis facilities, as well as stronger collaboration with universities, companies and research institutions. - FY2017-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥182 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reported cumulative third-quarter research and development expenses of ¥182 million and no material change in the status of its research and development activities. - FY2017-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥117 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company continued its research and development activities, reporting cumulative research and development expenses of ¥117 million for the quarter and no material change in the status of those activities. - FY2017-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥54 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company continued its research and development activities, reporting quarterly research and development expenses of ¥54 million and no material change in the status of those activities. - FY2016First statedAnnual report
「We will enrich research into elemental technologies within our core competencies, namely competitive core technologies, and accelerate development. We will further strengthen collaboration with leading companies, universities and other research institutions, and pursue the creation of original products in Japan and around the world.」
Measures to create original products through research into elemental technologies such as diaphragms, faster development and collaboration with external research institutions.